•
Jun 30, 2023

DaVita Q2 2023 Earnings Report

DaVita reported strong clinical outcomes and financial results due to focus on innovation and operational improvements.

Key Takeaways

DaVita Inc. announced its Q2 2023 financial results, with consolidated revenues of $3.0 billion. The company reported an operating income of $405 million and a diluted EPS of $1.91. Operating cash flow stood at $450 million, while free cash flow reached $260 million.

Consolidated revenues were $3.0 billion.

Operating income was $405 million and adjusted operating income was $432 million.

Diluted earnings per share was $1.91 and adjusted diluted earnings per share was $2.08.

Operating cash flow was $450 million and free cash flow was $260 million.

Total Revenue
$3B
Previous year: $2.93B
+2.5%
EPS
$2.08
Previous year: $2.3
-9.6%
US Dialysis Treatments
7.23M
Previous year: 7.27M
-0.5%
US Avg Treatments per day
92.71K
Previous year: 93.19K
-0.5%
US Dialysis Treatment Days
78
Gross Profit
$945M
Previous year: $910M
+3.8%
Cash and Equivalents
$327M
Previous year: $263M
+24.7%
Free Cash Flow
$260M
Previous year: $95M
+173.7%
Total Assets
$17B
Previous year: $17.1B
-0.8%

DaVita

DaVita

DaVita Revenue by Segment

DaVita Revenue by Geographic Location

Forward Guidance

DaVita provided its 2023 outlook, expecting adjusted operating income between $1.565 billion and $1.675 billion, adjusted diluted net income per share attributable to DaVita Inc. between $7.00 and $7.80, and free cash flow between $850 million and $1.1 billion.

Positive Outlook

  • Adjusted operating income between $1,565 million and $1,675 million.
  • Adjusted diluted net income per share attributable to DaVita Inc. between $7.00 and $7.80.
  • Free cash flow between $850 million and $1,100 million.

Challenges Ahead

  • The forward-looking measures and the underlying assumptions involve significant known and unknown risks and uncertainties.
  • Actual results may vary materially from these forward-looking measures.
  • The widespread impact of the COVID-19 pandemic continues to generate significant risk and uncertainty.
  • Future results could vary materially from the guidance provided.
  • Guidance excludes certain items, including capacity closure charges, severance costs and foreign currency fluctuations, which may be significant.

Revenue & Expenses

Visualization of income flow from segment revenue to net income